Skip to main content
Clinical Trials/ACTRN12611001094965
ACTRN12611001094965
Recruiting
N/A

The Effect of Whole-Body Vibration Treatment on Bone Metabolism in Breast Cancer Survivors who are undergoing Aromatase Inhibitor Therapy

Dr Michael Baker0 sites50 target enrollmentOctober 20, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Dr Michael Baker
Enrollment
50
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Dr Michael Baker

Eligibility Criteria

Inclusion Criteria

  • Currently taking an Aromatase Inhibitor drug for the treatment of breast cancer;
  • Willing to continue taking any bone altering medications or supplements they were previously taking for the duration of the study, including calcium and vitamin D;
  • Able to stand unassisted for sustained periods of time (i.e. 20 minutes)

Exclusion Criteria

  • Currently taking bisphosphonate medication;
  • Cognitive impairment;
  • Contraindications to vibration platform training (including pacemaker and fracture within the past six months);
  • Diagnosis of bone metastasis, and
  • Diagnosis of diseases other than osteoporosis affecting bone

Outcomes

Primary Outcomes

Not specified

Similar Trials